July 18, 2018
HHS Secretary Azar Announces Senior Advisor for Fourth Departmental Priority
On Wednesday, Health and Human Services Secretary Alex Azar announced that Adam Boehler, currently Director of the Center for Medicare & Medicaid Innovation (CMMI), will also begin serving as Senior Advisor for Value-Based Transformation and Innovation. Boehler is the fourth individual Azar has appointed to serve as a senior advisor to the secretary overseeing one of his four key departmental priorities, following the naming of Jim Parker as Senior Advisor to the Secretary for Health Reform and Director of the Office of Health Reform, Dan Best as Senior Advisor for Drug Pricing Reform, and Dr. Brett Giroir as Senior Advisor for Opioid and Mental Health Policy.
“Adam is the kind of results-oriented, transformational leader we need to deliver on what President Trump has promised the American people: better healthcare at a lower cost,” said Secretary Azar. “At CMMI, he has already demonstrated an ambition for bold change, and will now be able to bring his deep experience with private sector innovation to help HHS execute on the long-talked-about goal of transforming our healthcare system into one that pays for value.”
Since April, Boehler has served as Deputy Administrator and Director of the Center for Medicare & Medicaid Innovation. Boehler is the former CEO and founder of Landmark Health, a company focused on delivering medical services to the most chronically ill patients. Boehler is also the founder of Avalon Health Solutions, a leading provider of laboratory benefit management services in the country. Additionally, Boehler was an Operating Partner at Francisco Partners a leading global private equity firm focused on healthcare technology and services investing.
The senior advisers will help advance the four initiatives Secretary Azar has identified for his transformation agenda: combating the opioid crisis; bringing down the high cost of prescription drugs; addressing the cost and availability of health insurance; and transforming our healthcare system to a value-based system.
Since Dan Best’s appointment as Senior Advisor for Drug Pricing Reform, he has taken the lead on the department’s efforts to fulfill President Trump’s promise to lower drug prices, including the design and release of a comprehensive blueprint for lowering prices and out-of-pocket costs, taking numerous administrative actions that will lower prices, and working with pharmaceutical companies to secure voluntary price reductions. Best has brought decades of experience in the pharmaceutical and pharmacy-benefit manager industry to his work at HHS.
Since Jim Parker’s appointment as Senior Advisor to the Secretary for Health Reform and Director of the Office of Health Reform, he has led the department’s efforts to expand choice and competition in the individual and small-group insurance markets within the constraints of the Affordable Care Act. Parker has brought decades of knowledge of the health insurance industry to HHS health reform efforts.
Since Dr. Brett Giroir’s appointment as Senior Advisor for Mental Health and Opioid Policy, he has brought a new level of coordination to policy planning and implementation on the opioids crisis, from laying the groundwork to deliver more rapid data on the epidemic to coordinating historic research efforts across the department. Dr. Giroir brings to this task significant experience coordinating complicated federal scientific initiatives, including at the Department of Defense.
To learn more about the four priorities that Secretary Azar has identified for HHS to focus the Department’s work to improve the health and well-being of the American people, please visit: https://www.hhs.gov/about/leadership/secretary/priorities/index.html.